OncoZenge AB (publ) (STO:ONCOZ)
Sweden · Delayed Price · Currency is SEK 5.84
-0.25 (-4.11%)
Jan 21, 2026, 5:23 PM CET
OncoZenge AB Market Cap
OncoZenge AB has a market cap or net worth of 77.02 million as of January 21, 2026. Its market cap has increased by 67.96% in one year.
Market Cap
77.02M
Enterprise Value
72.93M
Revenue
2.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.84
Market Cap Chart
Since February 12, 2021, OncoZenge AB's market cap has decreased from 89.02M to 77.02M, a decrease of -13.48%. That is a compound annual growth rate of -2.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 72.97M | -14.64% |
| Dec 30, 2025 | 85.49M | 94.64% |
| Dec 30, 2024 | 43.92M | 21.36% |
| Dec 29, 2023 | 36.19M | -43.82% |
| Dec 30, 2022 | 64.42M | -52.42% |
| Dec 30, 2021 | 135.41M | 52.11% |
| Feb 12, 2021 | 89.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annexin Pharmaceuticals AB | 124.24M |
| Active Biotech AB | 112.30M |
| Biosergen AB | 93.93M |
| Pila Pharma AB | 89.64M |
| Spago Nanomedical AB | 85.67M |
| Karolinska Development AB | 83.65M |
| Scandinavian ChemoTech AB | 82.87M |
| Alzinova AB | 82.10M |